
Antidopaminergic Medications Worsen Outcomes in Huntington Disease, Study Shows
A recently published, 2-year causal analysis supported and extended previously reported findings that suggest antidopaminergic medications (ADM) worsen outcome measures in patients with Huntington disease (HD). To further validate these data, investigators …